Medical Tubing Market Share

North America Market Insights 

North America is the dominant player in the medical tubing market and is expected to hold the market share of 32.9% by 2037 at a CAGR of 7.4%. The market is mainly driven by the increase in healthcare infrastructure investment, aging population, and access to reimbursement via Medicare and Medicaid. More than 125.6 million people were insured by Medicare and Medicaid combined as of 2024, and demand is still being stimulated by the expansion of reimbursement codes for respiratory tubing and catheterization. The continued growth of the region is expected through localization strategies, national health coverage extensions, and favorable regulatory frameworks. The region will remain dominant due to the strong healthcare funding, active R&D innovation, and high disease burden.

The medical tubing market in the U.S. is positioned to showcase sustained growth driven by strong federal reimbursement reforms, healthcare expansion, and an aging population. As per Medicare, medical tubing-related reimbursements rose by 15.4% in the past five years, reaching USD 800.2 million. Increase in healthcare funding impacts the policy enhancements, allowing coverage of enteral feeding, dialysis, and respiratory tubing kits for elderly patients. Similarly, Medicaid has allocated USD 1.4 billion in 2024 to broaden access by 10.4% via inclusion in chronic illness packages.

Asia Pacific Regional Insights

The APAC is the fastest growing region in the medical tubing market and is projected to have a market share of 25.2% with a CAGR of 8.5% by 2037. The market is driven by rapid healthcare infrastructure expansion, rising chronic disease, increased surgical volumes and public investments in medical devices. The Asia Pacific region is emerging as a global production due to low manufacturing costs, proximity to raw materials and increasing policies. Infection control, sustainability, and import substitution are given top priority in government activities in these nations. APAC market has robust mid- to long-term prospects for manufacturers specializing in extrusion, material science, and sterile packaging as regulatory frameworks develop and local manufacturing picks up steam.

China holds the maximum share in the medical tubing market and is expected to hold the market share of 10.2% by 2037. As per NMPA, China, over the past five years, has increased the medical consumables such as tubing by 15.6%. Further, in 2023, over 1.7 million patients required tubing treatments, which is fueled by chronic disease prevalence and national insurance expansion. The Healthy China 2030 Plan prioritizes the use of tubing in diagnostics, surgeries, and infection control, and it provides tax rebates and raw material subsidies to local providers.

APAC Government Investment & Policy Table (2021–2025)

Europe Regional Insights

The medical tubing market in Europe is projected to hold a market share of 28.6% at a CAGR of 6.9% in 2037. The market in Europe is driven by a rising aging population, public health systems, expanded EU and national level investments in healthcare sectors. Germany and the UK hold the maximum share in the EU region and is largely contributed to chronic illness prevalence and transforming towards infection-resistant due to single-use tubing in ICUs and surgical settings. Further, the market in 2023 has expanded by over 10.3% every year with €500.3 million investment from the EU health fund. Factors such as innovation, cross border R&D and minimal investment in treatment infrastructure make the Europe market to have a stable, and regulatory friendly growth for tubing suppliers.

Germany holds the maximum share in the EU region and is expected to hold the market share of 8.9% by 2037. Various factors drive Germany’s medical tubing market, such as universal insurance coverage, robust public healthcare infrastructure, and DRG-based reimbursement for chronic and catheterization disease management. Germany's emphasis on preventing hospital-acquired infections has resulted in widespread use of tubes with antimicrobial coatings and biocompatible materials, which are now included in public procurement frameworks. As per the BMG report, nearly 70.4% of tertiary hospitals now use tubing replacement and sterilization guidelines. Germany is positioned to have a greater volume of innovation for both the EU and domestic supply.